|
|
| (One intermediate revision not shown) |
| Line 1: |
Line 1: |
| - | <html>
| |
| - | <head><title></title>
| |
| - | <style type="text/css">
| |
| - | #globalWrapper { background-color: transparent; border: none; margin: 0; padding: 0; width: 100%; height:100%;}
| |
| | | | |
| - | #bodyContent { border: none; padding:0; margin:0; width:100%; height:100%;}
| |
| - | #top-section { background-color: red; height: 0px; margin: 0px; margin-left: auto; margin-right: auto; margin-bottom: 0 !important;
| |
| - | padding:0; border: none; font-size: 10px;}
| |
| - | #p-logo { height:1px; overflow:hidden; display: none;}
| |
| - | #search-controls { overflow:hidden; display:block; background: none; position: absolute; top: 100px; right: 40px;}
| |
| - | .left-menu { width: 500px !important; display:block; margin-top:-80px; border: none; text-align: right;}
| |
| - | .left-menu ul { border: none; }
| |
| - | #menubar.right-menu { width:300px; display:block; float:left; margin-top:-80px; border: none;}
| |
| - | .right-menu ul { border: none; width: 300px;}
| |
| - | #footer-box { display: none; width: 100%; margin: -10px auto 0 auto; padding: 20px 0;}
| |
| - | .visualClear { display: none; }
| |
| - | #footer { border: none; width: 965px; margin: 0 auto; padding: 0;}
| |
| - | .firstHeading { display: none;}
| |
| - | #f-list a { color: #333; font-size: 10px;}
| |
| - | #f-list a:hover { color: #666;}
| |
| - | .printfooter { display: none; }
| |
| - | #footer ul { margin: 0; padding: 0;}
| |
| - | #footer ul li { margin-top: 0; margin-bottom: 0; margin-left: 0px; margin-right: 0px; padding: 0;}
| |
| - | #search-controls { display:none; }
| |
| - |
| |
| - | #contentSub {display: none;}
| |
| - |
| |
| - |
| |
| - | </style>
| |
| - | <style type="text/css">
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | <!--
| |
| - | A:link { COLOR: green; font-weight: normal }
| |
| - |
| |
| - | A:visited { COLOR: green; font-weight: normal }
| |
| - |
| |
| - | A:active { COLOR: green;}
| |
| - |
| |
| - | A:hover { COLOR: green; font-weight: normal ; text-decoration:underline}
| |
| - |
| |
| - |
| |
| - | -->
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | p{
| |
| - | font-family: Georgia, Helvetica, Arial, New Times Roman;
| |
| - | font-size:14;
| |
| - | line-height: 18pt;
| |
| - | font-weight:normal;
| |
| - | margin: 0px 20px 0px 20px;
| |
| - | text-align: justify;
| |
| - | }
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | table{
| |
| - | margin: 0px 0px 0px 0px
| |
| - | }
| |
| - | </style>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | </head>
| |
| - | <body bgcolor="#A1C6B2">
| |
| - |
| |
| - |
| |
| - | <table align=left style="border-collapse: collapse">
| |
| - | <TR>
| |
| - | <TH ROWSPAN=3 BGCOLOR="#A1C6B2">
| |
| - | <p>
| |
| - | <h3>1. ASM</h3>
| |
| - | <font color=black>
| |
| - |
| |
| - | </p>
| |
| - | <p >
| |
| - | <h4 align=left>1.2. Method of assembly</h4>
| |
| - | </p>
| |
| - | <p align=justify style="margin: 20px 20px 20px 20px">
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | To study the population dynamics and behavior of a certain antibiotics sensitive strain of E Coli in a medium of antibiotic, our E. Trojan that is introduced into the culture medium must not process a wide spectrum of antibiotic resistance that impose a selective advantage. At the same time, E. Trojan needs to be transformed with the T4MO gene to carry out its job of signal disruption.
| |
| - | <br><br>
| |
| - |
| |
| - | Summarizing the above criteria, a solution where the bacteria can be transform with the gene of interest while remaining sensitive to antibiotics is needed. Therefore the requisite is to construct a new bacteria strain that can perform plasmid selection without the use of antibiotics, and contains as little antibiotics resistance gene as possible.<br><br>
| |
| - |
| |
| - |
| |
| - | <b>Construction and maintenance of an antibiotic-resistance-gene-free plasmid through antibiotic selection – the unavoidable evil two plasmid system</b><br>
| |
| - |
| |
| - | Our ultimate goal is to construct our EX without conferring it any new antibiotic resistance. For this reason no resistance gene should be found in our dummy plasmid pDummy. <br><br>
| |
| - |
| |
| - | Yet, such a plasmid would not be maintained by itself unless the host bacterium develops an addiction to it (i.e. losses the essential gene in its genome and depends on extragenomic copies on pDummy), and inconveniently, the addiction can only be achieved after the introduction of the plasmid.<br><br>
| |
| - |
| |
| - | The solution is to develop a mutualistic relation between two plasmids and we planned to exploit positively regulated origin of replications. Well studied examples are those in pSC101 and R6K origins of replication, where the origins of replication (OR) appear together with a constitutive gene (G). Initiation of replication happens if and only if the trans element of the gene is provided.<br></p>
| |
| - |
| |
| - | <p>
| |
| - | Let’s consider the following scenario: <br>
| |
| - | i. G is placed on pDummy with no selection marker but with a normal replication origin<br>
| |
| - | ii. OR is the sole origin of replication of another plasmid (pToolkit) with a selection marker<br>
| |
| - | iii. pDummy and pToolkit are co-transformed to a bacterium which is under selection stress</p>
| |
| - | <br>
| |
| - | <p>
| |
| - | We would obtain three possible outcomes:<br>
| |
| - | <b>1. only pDummy is uptaken</b><br>
| |
| - | - since pDummy has no selection marker, the host bacteria die under selection pressure and cannot propagate<br><br>
| |
| - | <b>2. only pToolkit is uptaken</b><br>
| |
| - | - the host bacterium that uptakes pToolkit survives. Yet during propagation, pToolkit is not replicated because proteins of G are absent. Therefore daughter cells of the host bacterium will not receive copies of the pToolkit and die under selection pressure.<br><br>
| |
| - | <b>3. both pDummy and pToolkit are uptaken</b><br>
| |
| - | - in presence of pDummy, pToolkit is maintained and confers the host bacterium with stress resistance. Daughters that receive copies of both plasmids will survive and eventually develop into a colony.<br><br></p>
| |
| - |
| |
| - |
| |
| - | <p>
| |
| - | Using this mutualistic relation, the desired pDummy can be maintained once the host bacterium develops an addiction it, and pToolkit can be lost in bacteria propagation if the expression of G can be shut off manually. Eventually, the bacteria not obtain any new antibiotic resistance genes but keep pDummy.
| |
| - |
| |
| - | </p>
| |
| - | <p align=justify style="margin: 20px 20px 20px 20px">
| |
| - | <b>Development of addiction – use of the lambda RED recombination system</b><br>
| |
| - |
| |
| - | To develop the addiction in the host bacterium to pDummy, an essential gene for survival is to be deleted from the bacteria genome, provided that the bacteria can survive on extra-genomic copies after the deletion.<br><br>
| |
| - |
| |
| - | The deletion here is mediated through the lambda RED recombination system.<br><br>
| |
| - |
| |
| - |
| |
| - | The lambda RED recombination cassette is located on the pToolkit (and hence the name of the plasmid). Once the recombination is successful, it can be eliminated from the host bacterium together with the antibiotic resistance gene. <br><br>
| |
| - |
| |
| - | Therefore, once the co-transformation of pDummy and pToolkit is successful, linear dsDNAs having a reporter gene flanked by homologous sequences to the essential gene can be introduced into the bacteria. When the recombination is kicked started, the essential gene will be swapped out and the reporter gene will be incorporated into the bacteria genome.<br><br>
| |
| - |
| |
| - | Since the linear dsDNAs do not have origin of replications, they are not inherited in daughters unless they are swapped into the genomes. Thus, any observable signals from the reporter would allow identification of successful recombination. Identified colonies can then be further treated to induce loss of pToolkit, which afterwards would be the completed strain of EX.<br><br>
| |
| - |
| |
| - | <b>Complementation between reporter genes – manifesting completion of EX engineering</b><br>
| |
| - |
| |
| - | To ensure that the final strain of EX has: 1. successfully had its essential gene deleted from genome, 2. maintained the pDummy, a complementation reporter system between the pDummy and swapped gene is preferred over a single reporter at the swapped site.<br><br>
| |
| - |
| |
| - | Different methods can achieve the above aim:<br>
| |
| - | i. Alpha complementation can be used in E. Coli strains where the lacZ gene is completely removed. The larger fragment ω can be swapped for the essential gene while the smaller α fragment can stay on pDummy. In a X-gal rich medium, blue colonies suggest the desired engineered strains.<br><br>
| |
| - |
| |
| - | ii. Complementation between split fluorescent proteins (sFP). 2010 iGEM Slovenia team has demonstrated the principle that N-terminal and C-terminal fragments of sFPS are able to complement in vivo and two sets of sfFPS are able to undergo Förster resonance energy transfer (FRET). This idea is adopted but an alternative set of candidate, split superfolder GFPs (sfGFP), was developed.</p>
| |
| - |
| |
| - | <h5 align=left>Summary of construction flow:</h5>
| |
| - | <p>1. Assembly pDummy and pToolkit<br>
| |
| - | 2. Co-transform both plasmid into E Coli and maintain stable strains<br>
| |
| - | 3. Introduce linear dsDNAs and induce recombination<br>
| |
| - | 4. Isolate recombinants<br>
| |
| - | 5. Induce loss of pToolkit
| |
| - | </p>
| |
| - |
| |
| - |
| |
| - | <A href=overviewc.html target=_top>Continue</a>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | </font>
| |
| - |
| |
| - | </TH>
| |
| - |
| |
| - | <TD bgcolor="white">
| |
| - | <p>
| |
| - |
| |
| - | <h2>Overview & Background</h2>
| |
| - |
| |
| - | </font>
| |
| - | </p>
| |
| - | <br><br><br><br>
| |
| - |
| |
| - | 1 ASM <br>
| |
| - | 1.1 Theory – how to select? <br>
| |
| - | 1.2 Method of assembly<br>
| |
| - | 1.3 Component details<br><br>
| |
| - |
| |
| - |
| |
| - |
| |
| - | Next on<a href=overviewc.html target=_top>1.3 Component details</a>
| |
| - | </TD>
| |
| - |
| |
| - |
| |
| - | </TR>
| |
| - |
| |
| - | <TR>
| |
| - | <TD bgcolor=white ><p>
| |
| - |
| |
| - |
| |
| - |
| |
| - | </TD>
| |
| - | </TR>
| |
| - |
| |
| - |
| |
| - | <TR>
| |
| - | <TD bgcolor=#182828 height=640><p>
| |
| - | <font color=#CDD2C2>
| |
| - |
| |
| - | </font>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | </TD>
| |
| - | </TR>
| |
| - |
| |
| - |
| |
| - |
| |
| - | </table>
| |
| - |
| |
| - |
| |
| - | <br>
| |
| - | <table border="0" cellspacing="0" cellpadding="1">
| |
| - | <tr>
| |
| - | <td bgcolor="#980000" width=240 height=10 >
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - | <td bgcolor="#CCFF99" width=240 height=10>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - |
| |
| - | <td bgcolor="#D09C00" width=240 height=10>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - |
| |
| - | <td bgcolor="#980000" width=240 height=10>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - | </tr>
| |
| - | </table>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | <table>
| |
| - | <tr>
| |
| - | <td>
| |
| - |
| |
| - | <ul>
| |
| - | Home
| |
| - | <li><a href="main.html" target=_top>Home</a></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | Acknowledgements
| |
| - | <li><a href="acknowledgement.html" target=_top>Acknowledgements</a></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | iGEM team list
| |
| - | <li><a href="track.html" target=_top>Track choice</a></li>
| |
| - | <li><a href="team.html" target=_top>Member list</a></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - |
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | Project
| |
| - | <li><a href="overview.html" target=_top>Overview & Background</a></li>
| |
| - | <li><a href="modeling.html" target=_top>Modeling</a></li>
| |
| - | <li><a href="future.html" target=_top>Future Applications</a></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | Notebook
| |
| - | <li><a href="notebook.html" target=_top>Notebook</a></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | Biobricks
| |
| - | <li><a href="characterization.html" target=_top>Master list & Characterization
| |
| - | </a></li>
| |
| - | <li><a href="links.html" target=_top>Links to partsregistry</a></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - |
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | BioSafety
| |
| - | <li><a href="biosafety.html" target=_top>BioSafety</a></li>
| |
| - | <li></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | Achievements
| |
| - | <li><a href="medal.html" target=_top>Medal Awards</a></li>
| |
| - | <li><a href="contribution.html" target=_top>Contributions</a></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - |
| |
| - | <td>
| |
| - | <ul>
| |
| - | Human Practice
| |
| - | <li><a href="human.html" target=_top>Workshop</a></li>
| |
| - | <li><a href="survey.html" target=_top>Survey
| |
| - | </a></li>
| |
| - | <li></li>
| |
| - | </ul>
| |
| - |
| |
| - | </td>
| |
| - | </tr>
| |
| - | </table>
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - |
| |
| - | </body>
| |
| - | </html>
| |
"
